We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Established in 2011, Crowdcube has become the market leader in the equity crowdfunding sector. The company has a 40% share of the UK market with over 620,000 investors registered on the platform that have invested more than £561m in pitches. This has resulted in nearly 800 successful campaigns and Crowdcube's revenue increasing by 33% from H1 2017 to H1 2018. Funds are being raised to scale the business by expanding further in the UK, as well as overseas.
days to go: Expired investment: £7,918,180
WhiskyInvestDirect leverages BullionVault’s proven model of crowdfunding wholesale bullion bars (25,000 UK clients) and applies it to maturing whisky. The model eliminates the key working capital constraint experienced by producers, whilst users can potentially profit as the whisky increases in value. The team includes the founder and CEO of BullionVault and an ex-Commercial Director at Diageo who has been building whisky brands for the last 24 years.
days to go: Expired investment: £1,076,472
Baanx is a Business to Business to Consumer (B2B2C) banking platform that is Application Programming Interface (API) driven and digital-friendly. It aims to become a contender in the digital asset financial services market that is expected to rise and expand to over 580 million people or 7+% of the world population by 2022. Baanx argues that it is disrupting the slow and expensive banking sector by leveraging blockchain to launch secure and low-cost banking products and services, with a few lines of code. Baanx offers its users 'Digital wallets' (via API or a custom mobile app), crypto-friendly debit cards in physical and virtual formats, and allows users to send fiat or cryptocurrencies to anyone in their contact list with 'zero' Foreign Exchange (FX) fees, through its proprietary software, TextBit.  
days to go: Expired investment: £9,500,000
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £70,900
CoinBurp is a uniquely user-friendly crypto trading platform. It has a long-term vision to become an international brand and an integral part of the banking ecosystem. The company has acquired more than 1,000 users and facilitated 1000+ transactions, accumulating a trading volume of more than £1m. As CoinBurp enters its second phase of product development, it aims at providing banking facilities such as provide customers with prepaid cards, offer secured crypto loans and have initiated the process to become FCA regulated.

Pitch Rated

66%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,630
Chip is a savings and investment portal. The company has over 250,000 registered users, processed over £165 million in savings, achieved Financial Conduct Authority (FSA) authorisation and launched Financial Services Compensation Scheme (FSCS) eligible interest accounts with market-leading rates. It aims to be the go to investment platform for the mobile generation that consists of 100 million customers and 30 trillion assets across Europe. Chip started with autosaving and seamless access to market-leading saving accounts. With its premium account ChipX, the company is venturing into investment funds, savings accounts, and pensions. It will use the investment to open up its investor community to new and existing investors to participate in this convertible round. It will also initiate discussions with venture capitalists to secure a follow up investment.
days to go: Expired investment: £11,403,860
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph